Spots Global Cancer Trial Database for Pediatric Long-Term Follow-up and Rollover Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pediatric Long-Term Follow-up and Rollover Study
Official Title: An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib)
Study ID: NCT03975829
Conditions
Study Description
Brief Summary: A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
Detailed Description:
Eligibility
Minimum Age: 1 Year
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Phoenix Children's Hospital ., Phoenix, Arizona, United States
Childrens National Hospital CQTI571A2306, Washington, District of Columbia, United States
Nicklaus Childrens Hospital, Miami, Florida, United States
Indiana Uni School of Medicine ., Indianapolis, Indiana, United States
Johns Hopkins University IDS Pharmacy, Baltimore, Maryland, United States
Dana Farber Cancer Institute ., Boston, Massachusetts, United States
University of Minnesota ., Minneapolis, Minnesota, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Cinn Children Hosp Medical Center, Cincinnati, Ohio, United States
St Jude Childrens Research Hospital ., Memphis, Tennessee, United States
Texas Children's Hospital, Houston, Texas, United States
Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, Darlinghurst, New South Wales, Australia
Novartis Investigative Site, Parkville, Victoria, Australia
Novartis Investigative Site, Bruxelles, , Belgium
Novartis Investigative Site, Barretos, SP, Brazil
Novartis Investigative Site, Sao Paulo, SP, Brazil
Novartis Investigative Site, Sao Paulo, SP, Brazil
Novartis Investigative Site, Vancouver, British Columbia, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Brno, , Czechia
Novartis Investigative Site, Praha 5, , Czechia
Novartis Investigative Site, Copenhagen, , Denmark
Novartis Investigative Site, Tampere, , Finland
Novartis Investigative Site, Rennes, Bretagne, France
Novartis Investigative Site, Brest Cedex, Finistere, France
Novartis Investigative Site, Marseille Cedex 05, , France
Novartis Investigative Site, Paris, , France
Novartis Investigative Site, Vandoeuvre Les Nancy, , France
Novartis Investigative Site, Villejuif, , France
Novartis Investigative Site, Augsburg, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Essen, , Germany
Novartis Investigative Site, Hamburg, , Germany
Novartis Investigative Site, Koeln, , Germany
Novartis Investigative Site, Petach-Tikva, , Israel
Novartis Investigative Site, Firenze, FI, Italy
Novartis Investigative Site, Genova, GE, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Torino, TO, Italy
Novartis Investigative Site, Setagaya-ku, Tokyo, Japan
Novartis Investigative Site, Osaka, , Japan
Novartis Investigative Site, Utrecht, CS, Netherlands
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Valencia, , Spain
Novartis Investigative Site, Stockholm, , Sweden
Novartis Investigative Site, Sutton, Surrey, United Kingdom
Novartis Investigative Site, Liverpool, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
